Mild cognitive impairment [8]

New England Journal of Medicine

Volumn 365, Issue 14, 2011, Pages 1358-

  Chukwujama, Ogo ^a   Gormley, Niall ^a  

^a St Senan's Hospital   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; PLACEBO; VITAMIN B GROUP;

BRAIN ATROPHY; CEREBROVASCULAR DISEASE; COGNITION; DEMENTIA; DRUG EFFICACY; EXERCISE; HUMAN; LETTER; MEMORY; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REHABILITATION CARE; SENSORIMOTOR FUNCTION; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

DEMENTIA; FEMALE; HUMANS; MEMORY DISORDERS;

EID: 80053545741     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Durga J, Van Boxtel MPJ, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomized, double blind, controlled trial. Lancet 2007;369:208-16. (Pubitemid 46107683)
2. Smith AD, Smith SM, De Jager CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS ONE 2010;5(9):e12244.